Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) EBT Margin (2020 - 2025)

Historic EBT Margin for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 95.06%.

  • Biofrontera's EBT Margin fell 321900.0% to 95.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.22%, marking a year-over-year decrease of 109700.0%. This contributed to the annual value of 47.53% for FY2024, which is 115200.0% up from last year.
  • As of Q3 2025, Biofrontera's EBT Margin stood at 95.06%, which was down 321900.0% from 58.73% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's EBT Margin ranged from a high of 57.34% in Q1 2022 and a low of 369.31% during Q3 2021
  • For the 5-year period, Biofrontera's EBT Margin averaged around 74.5%, with its median value being 61.78% (2021).
  • Per our database at Business Quant, Biofrontera's EBT Margin crashed by -2794000bps in 2021 and then skyrocketed by 3099600bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's EBT Margin stood at 158.16% in 2021, then skyrocketed by 83bps to 27.44% in 2022, then soared by 221bps to 33.22% in 2023, then plummeted by -134bps to 11.14% in 2024, then crashed by -753bps to 95.06% in 2025.
  • Its EBT Margin was 95.06% in Q3 2025, compared to 58.73% in Q2 2025 and 48.95% in Q1 2025.